Korean J Pathol.  1996 Aug;30(8):699-705.

EBV in Situ Hybridization Study for Cutaneous T-Cell Lymphomas

Affiliations
  • 1Departments of Pathology, College of Medicine, Hanyang University, Seoul, Korea.
  • 2Departments of Dermatology, College of Medicine, Hanyang University, Seoul, Korea.

Abstract

We studied 24 cases of cutaneous T-cell lymphomas and six cases of benign lymphoproliferative diseases of the skin (2 Jessner's lymphocytic infiltration, 2 pseudolymphoma, 2 lymphomatoid papulosis) for the presence of Epstein-Barr Virus(EBV) RNA, using the in situ hybridization(ISH) method. Among the 24 cases of cutaneous T-cell lymphomas (CTCL), 18 cases including 12 cases of mycosis fungoides(MF) were primary CTCL, and the other 6 cases were secondary CTCL. The ISH study demonstrated a positive reaction for EBER probe in 6 out of the 24 cases(25%) of CTCL, and a negative reaction for BHLF nuclear RNA probe in all the cases studied. Double-labelling immunohistochemistry/ISH studies revealed that the EBV positive cells were CD45RO positive and CD20 negative. EBV genome was not demonstrated in any benign lymphoproliferative diseases of the skin. Among the EBER positive cases, none of the 12 cases of MF demonstrated EBER signals, and 6 out of the 12(50%) cases of CTCL were positive for EBER probe. In conclusion, latent infection of EBV may play a role in the development of non-mycosis fungoides T-cell lymphomas involving the skin.

Keyword

Epstein-barr virus; Cutaneous T-cell lymphomas

MeSH Terms

Genome
Herpesvirus 4, Human*
In Situ Hybridization*
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous*
Pseudolymphoma
RNA
RNA, Nuclear
Skin
RNA
RNA, Nuclear
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr